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Editorial on the Research Topic
The Neurodietetics and Genetics of Copper and Iron
It is with great pleasure that we present this Research Topic dedicated to handling of transient
metals and their function in the brain. Iron and copper are important co-factors for a number
of enzymes in the brain, which are involved in multiple processes including neurotransmitter
synthesis and myelin formation. Both shortage and excess of copper and iron will negatively
influence brain function. The transport of copper and iron from peripheral circulation into the
brain is strictly regulated and the concordantly protective blood-brain and blood-cerebrospinal
fluid barriers have evolved to protect the brain’s internal environment from unwanted exposure
from the periphery. The sites for uptake and transport of copper and iron into the brain overlap, and
the uptake mechanisms of the two metals significantly interact: Both iron deficiency and overload
lead to altered copper homeostasis in the brain. Similarly, changes in dietary copper influences the
cerebral iron homeostasis.
For long the focus of research on copper and iron in the brain has had a mainstay on the
significance of molecules in the brain using these metals as co-factors. Moreover, the understanding
of transport of the metals through the blood-brain and blood-cerebrospinal fluid barriers and the
understanding of the further handling of the metals inside the brain have received prioritizing from
many research groups. Naturally, the possibility of nutritional deficiency caused by insufficient
dietary supply of copper and iron has also gained interest, and attempts to delineate the impact
of dietary insufficient on the brain, not at least the developing brain, are important topics that
could aid in understanding periods during development where sufficient metal supply could be a
highest importance.
In 2015, we launched this Research Topic with the intention to provide a platform for
presentation of research on the significance of copper and iron for the brain. This Research Topic
mainly covers: (i) the genetics of proteins handling copper and iron in the brain, (ii) the expression
and function of copper- and iron proteins in normal and pathological conditions; (iii) the clinic
manifestations of dietary deficiencies in copper or iron; (iv) the clinic manifestation of genetic
diseases leading to mishandling of copper and iron; (v) therapeutic aspects of handling dietary
deficiencies, overloading pathologies, or conditions with genetic mutations in proteins related to
copper and iron.
Møller et al. show that protein variants encoded by ATP7A transcripts missing either exon
10 or exon 15 are not functional and not responsible for the so-called occipital horn syndrome
(OHS) phenotype, a mild variant of Menkes disease with mutation in the ATP7A gene. Prior
studies have shown that only minor copper dependent transcriptional regulation of the ATP7A and
ATP7B genes are apparent. In agreement with lack of rapid transcriptional regulation, the study
of Lenartowicz et al. shows that a high copper concentration pressure leads to cellular selection.
Interestingly, normal cells encoding the ATP7A gene have selective growth advantages at high
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copper concentrations, whereas cells without functional
ATP7A has selective growth advantage toward low copper
concentrations. The review by Lenartowicz et al. reports on
the Mottle mouse, which closely recapitulates the phenotype of
Menkes disease and leads to multi-systemic copper metabolism
disorder caused by mutations in the X-linked ATP7A gene.
Lessons from studies in the Mottled mouse reveal that the
ATP7A protein is expelling copper from certain cells including
cells in the kidney, intestine, placenta and testis, and that
deficiency in ATP7A function leads to excessive or even toxic
amounts of copper in these tissues and at the same time lack of
copper in other tissues. Fu et al. show in their study on the role
of copper in the developing ventricular system in the rat, that
copper levels increase as a function of age, and subventricular
zone shows a different expression pattern of Cu-regulatory genes
than seen in the choroid plexus. An age-related increase in the
copper-binding protein MTs and a simultaneous decrease in
Ctr1 may contribute to the high copper level in this neurogenesis
active brain region. The review of Skjørringe et al. discusses the
role of the divalent metal transporter 1 (DMT1) for handling iron
transport at the blood-brain barrier (BBB). DMT1 is detectable in
endosomes of brain capillary endothelial cells denoting the BBB.
Iron uptake at the BBB occurs by means of transferrin-receptor
mediated endocytosis followed by detachment of iron from
transferrin inside the acidic compartment of the endosome.
McCarthy and Kosman discuss the transendothelial trafficking
of iron at the BBB by covering mechanisms by which brain
endothelial cells take-up iron from the blood and by which
they efflux this iron into the abluminal space mediated by
ferroportin. They also cover the regulation of iron efflux into
the brain by exocrine factors released from adjacent astrocyte-
end feet, and how cytokines secreted by the endothelial cells
conversely may regulate such glial signaling. Codazzi et al.
reviews the mechanisms responsible for non-transferrin-bound
iron (NTBI) entry in neurons and astrocytes and on how they
can be modulated during synaptic activity, not at least under
the influence of calcium permeable channels and DMT1. They
also in-depth speculate how NBTI might have relevance for
cellular iron homeostasis in both physiological and pathological
conditions. Gajowiak et al., studied changes in iron metabolism
in a mouse model of amyotrophic lateral sclerosis (ALS). They
report that overexpression of mutated SOD1G93A leads to
pathological changes in a skeletal muscle with deposits of iron.
This research forum hence covers many important
characteristics of metal biology in the brain, and the advances
thereof included within this Research Topic indeed brings
novelty to the understanding of how the neurons and glial cells
handles copper and iron to enable the significance of these
essential metals for the brain.
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